IS DRUG CHALLENGE TEST WITH PROPAFENONE ADEQUATE TO EXCLUDE BRUGADA SYNDROME?

dc.contributor.authorYildiz, Serhat Bekir
dc.contributor.authorGungor, Hasan
dc.contributor.authorGul, Ilker
dc.contributor.authorAkin, Mustafa
dc.contributor.authorZoghi, Mehdi
dc.contributor.authorAkilli, Azem
dc.date.accessioned2019-10-27T21:18:20Z
dc.date.available2019-10-27T21:18:20Z
dc.date.issued2010
dc.departmentEge Üniversitesien_US
dc.identifier.doi10.1016/S0167-5273(10)70314-4
dc.identifier.endpageS88en_US
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.startpageS88en_US
dc.identifier.urihttps://doi.org/10.1016/S0167-5273(10)70314-4
dc.identifier.urihttps://hdl.handle.net/11454/43965
dc.identifier.volume140en_US
dc.identifier.wosWOS:000209824900312en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofInternational Journal of Cardiologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIS DRUG CHALLENGE TEST WITH PROPAFENONE ADEQUATE TO EXCLUDE BRUGADA SYNDROME?en_US
dc.typeConference Objecten_US

Dosyalar